Your browser doesn't support javascript.
loading
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Colombel, Jean-Frederic; Panaccione, Remo; Bossuyt, Peter; Lukas, Milan; Baert, Filip; Vanásek, Tomas; Danalioglu, Ahmet; Novacek, Gottfried; Armuzzi, Alessandro; Hébuterne, Xavier; Travis, Simon; Danese, Silvio; Reinisch, Walter; Sandborn, William J; Rutgeerts, Paul; Hommes, Daniel; Schreiber, Stefan; Neimark, Ezequiel; Huang, Bidan; Zhou, Qian; Mendez, Paloma; Petersson, Joel; Wallace, Kori; Robinson, Anne M; Thakkar, Roopal B; D'Haens, Geert.
Afiliação
  • Colombel JF; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: jean-frederic.colombel@mssm.edu.
  • Panaccione R; Inflammatory Bowel Disease Unit, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Bossuyt P; Imelda General Hospital, Bonheiden, Belgium.
  • Lukas M; Clinical and Research Centre for Inflammatory Bowel Disease, ISCARE Clinical Centre, Prague, Czech Republic; First Medical Faculty, Charles University, Prague, Czech Republic.
  • Baert F; AZ Delta, Roeselare-Menen, Belgium.
  • Vanásek T; Hepato-Gastroenterologie HK, sro, Hradec Králové, Czech Republic.
  • Danalioglu A; Department of Gastroenterology, Bezmialem Vakif University, Istanbul, Turkey.
  • Novacek G; Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Armuzzi A; Presidio Columbus, Fondazione Policlinico Gemelli Università Cattolica, Rome, Italy.
  • Hébuterne X; Service de Gastro-entérologie et Nutrition Clinique, Nice, France; Université de Nice-Sophia-Antipolis, Nice, France.
  • Travis S; Oxford University Hospitals, Oxford, UK.
  • Danese S; Department of Biomedical Sciences, Humanitas University, Milan, Italy; Humanitas Clinical and Research Centre, Milan, Italy.
  • Reinisch W; Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Sandborn WJ; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Rutgeerts P; Department of Gastroenterology, University of Leuven, Leuven, Belgium.
  • Hommes D; Department of Medicine, University of California, Los Angeles, CA, USA.
  • Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Neimark E; AbbVie Inc, North Chicago, IL, USA.
  • Huang B; AbbVie Inc, North Chicago, IL, USA.
  • Zhou Q; AbbVie Inc, North Chicago, IL, USA.
  • Mendez P; AbbVie Spain SLU, Madrid, Spain.
  • Petersson J; AbbVie Inc, North Chicago, IL, USA.
  • Wallace K; AbbVie Inc, North Chicago, IL, USA.
  • Robinson AM; AbbVie Inc, North Chicago, IL, USA.
  • Thakkar RB; AbbVie Inc, North Chicago, IL, USA.
  • D'Haens G; Academic Medical Center, Amsterdam, Netherlands.
Lancet ; 390(10114): 2779-2789, 2017 12 23.
Article em En | MEDLINE | ID: mdl-29096949
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azatioprina / Doença de Crohn / Antirreumáticos / Adalimumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azatioprina / Doença de Crohn / Antirreumáticos / Adalimumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article